| General Information of Drug Metabolite (DM) (ID: DM018978) |
| DM Name |
LEE011 Metabolite M13
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Flavin-containing monooxygenase (FMO)
|
DMEN075
|
| Unclear - Unclear |
LEE011
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| LEE011 |
DR3423
|
Phase 3 |
Solid tumour/cancer |
|
|
| References |
| 1 |
An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
